Partner with BRI to build a healthy immune system for everyone
BRI collaborates with other research organizations, providing available technologies and materials, and conducting clinical trials in a broad range of disease areas. BRI works collaboratively with scientists in pharmaceutical and biotechnology companies and life science research institutions throughout the world on immune mediated and other diseases. We welcome the opportunity to explore potential research collaborations with you on the human immune system including autoimmune diseases, cancer, allergies, and asthma.
Opportunities for collaboration using BRI Resources
BRI resources offer unique access to samples, innovative tools and expertise to fuel research discoveries.
Research Collaborations Using BRI Biorepositories
Build a Tetramer
Human Immunophenotyping Core
The Human Immunophenotyping (HIP) core at the Benaroya Research Institute (BRI) provides access to cutting-edge technologies and services enabling study of human immune-mediated diseases. A full spectrum of services is available, from guidance on study design and training on new technologies through to execution, data analysis and interpretation. The HIP core serves investigators from BRI and Virginia Mason Medical Center (VMMC) as well as other institutions, including both non- and for-profit organizations.
Opportunities for collaboration: Research Areas
From basic science breakthroughs to clinical stage testing, BRI research advances discovery and understanding of the human immune system.